01 1Gowling Lafleur Henderson LLP
01 11340417
01 1Cetuximab
01 1Solution
01 12016-03-02
Patent Expiration Date : 2016-03-02
Date Granted : 1999-03-02
Brand Name : ERBITUX
Patent Number : 1340417
Filing Date : 1989-09-13
Strength per Unit : 2 mg / mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous Injection
Patent Expiration Date : 2016-03-02
Date Granted : 1999-03-02
LOOKING FOR A SUPPLIER?